Literature DB >> 31177980

Letter by Gutierrez Regarding Article, "Dual Antiplatelet Therapy Improves Functional Outcome in Patients With Progressive Lacunar Strokes".

Jose Gutierrez1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31177980      PMCID： PMC6591065          DOI： 10.1161/STROKEAHA.119.025708

Source DB:  PubMed          Journal:  Stroke        ISSN： 0039-2499            Impact factor:   7.914


× No keyword cloud information.
  5 in total

Review 1.  Intracranial branch atheromatous disease: a neglected, understudied, and underused concept.

Authors:  L R Caplan
Journal:  Neurology       Date:  1989-09       Impact factor: 9.910

2.  Dual Antiplatelet Therapy Improves Functional Outcome in Patients With Progressive Lacunar Strokes.

Authors:  Anne Berberich; Christine Schneider; Tilman Reiff; Christoph Gumbinger; Peter Arthur Ringleb
Journal:  Stroke       Date:  2019-04       Impact factor: 7.914

3.  Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial.

Authors:  Pierre Amarenco; Gregory W Albers; Hans Denison; J Donald Easton; Scott R Evans; Peter Held; Michael D Hill; Jenny Jonasson; Scott E Kasner; Per Ladenvall; Kazuo Minematsu; Carlos A Molina; Yongjun Wang; K S Lawrence Wong; S Claiborne Johnston
Journal:  Lancet Neurol       Date:  2017-02-23       Impact factor: 44.182

4.  Dual antiplatelet therapy in stroke and ICAS: Subgroup analysis of CHANCE.

Authors:  Liping Liu; Ka Sing Lawrence Wong; Xinyi Leng; Yuehua Pu; Yilong Wang; Jing Jing; Xinying Zou; Yuesong Pan; Anxin Wang; Xia Meng; Chunxue Wang; Xingquan Zhao; Yannie Soo; S Claiborne Johnston; Yongjun Wang
Journal:  Neurology       Date:  2015-09-29       Impact factor: 9.910

5.  Author response: Risks and benefits of clopidogrel-aspirin in minor stroke or TIA: Time course analysis of CHANCE.

Authors:  Yuesong Pan; Yilong Wang; Yongjun Wang
Journal:  Neurology       Date:  2017-11-14       Impact factor: 9.910
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.